The small contribution of Treg cells (both in terms of TCR diversity and clonal abundance) expressing an exclusive set of TCRs and preexisting in healthy mice to the population of Foxp3+ T cells in tumors is surprising, especially considering that these cells still constitute a significant proportion of Foxp3+ Treg cells in the tumor draining lymph nodes. This evidence concerns the gene FOXP3 and neoplasm.